RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Medtronic Stock

Medtronic Net Income 2024

Medtronic Net Income

3.68 B USD

Ticker

MDT

ISIN

IE00BTN1Y115

WKN

A14M2J

In 2024, Medtronic's profit amounted to 3.68 B USD, a -2.18% increase from the 3.76 B USD profit recorded in the previous year.

The Medtronic Net Income history

YEARNET INCOME (undefined USD)
2030e10.16
2029e9.57
2028e8.76
2027e8.17
2026e7.58
2025e7.07
20243.68
20233.76
20225.04
20213.61
20204.79
20194.63
20183.1
20174.03
20163.54
20152.68
20143.07
20133.47
20123.62
20113.1
20103.1
20092.07
20082.14
20072.8
20062.55
20051.8

Medtronic Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Medtronic, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Medtronic from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Medtronic’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Medtronic. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Medtronic’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Medtronic’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Medtronic’s growth potential.

Medtronic Revenue, EBIT and net profit per share

DateMedtronic RevenueMedtronic EBITMedtronic Net Income
2030e43.24 B undefined0 undefined10.16 B undefined
2029e41.01 B undefined11.4 B undefined9.57 B undefined
2028e39.33 B undefined10.6 B undefined8.76 B undefined
2027e37.36 B undefined9.8 B undefined8.17 B undefined
2026e35.59 B undefined9.33 B undefined7.58 B undefined
2025e33.96 B undefined8.75 B undefined7.07 B undefined
202432.36 B undefined6.12 B undefined3.68 B undefined
202331.23 B undefined6.35 B undefined3.76 B undefined
202231.69 B undefined6.91 B undefined5.04 B undefined
202130.12 B undefined5.4 B undefined3.61 B undefined
202028.91 B undefined5.56 B undefined4.79 B undefined
201930.56 B undefined6.9 B undefined4.63 B undefined
201829.95 B undefined6.66 B undefined3.1 B undefined
201729.71 B undefined5.96 B undefined4.03 B undefined
201628.83 B undefined5.96 B undefined3.54 B undefined
201520.26 B undefined4.77 B undefined2.68 B undefined
201417.01 B undefined4.83 B undefined3.07 B undefined
201316.59 B undefined4.8 B undefined3.47 B undefined
201216.18 B undefined4.49 B undefined3.62 B undefined
201115.51 B undefined4.48 B undefined3.1 B undefined
201015.39 B undefined4.68 B undefined3.1 B undefined
200914.6 B undefined4.18 B undefined2.07 B undefined
200813.52 B undefined3.66 B undefined2.14 B undefined
200712.3 B undefined3.54 B undefined2.8 B undefined
200611.29 B undefined3.54 B undefined2.55 B undefined
200510.06 B undefined3.15 B undefined1.8 B undefined

Medtronic stock margins

The Medtronic margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medtronic. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medtronic.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Medtronic's sales revenue. A higher gross margin percentage indicates that the Medtronic retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Medtronic's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Medtronic's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Medtronic's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Medtronic. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Medtronic's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Medtronic Margin History

Medtronic Gross marginMedtronic Profit marginMedtronic EBIT marginMedtronic Profit margin
2030e65.73 %0 %23.49 %
2029e65.73 %27.8 %23.33 %
2028e65.73 %26.94 %22.28 %
2027e65.73 %26.24 %21.87 %
2026e65.73 %26.22 %21.29 %
2025e65.73 %25.77 %20.8 %
202465.73 %18.91 %11.36 %
202365.98 %20.32 %12.03 %
202268.53 %21.8 %15.9 %
202165.62 %17.91 %11.97 %
202067.94 %19.24 %16.56 %
201970.34 %22.58 %15.16 %
201869.82 %22.22 %10.36 %
201768.81 %20.06 %13.56 %
201668.29 %20.67 %12.27 %
201568.86 %23.53 %13.2 %
201474.52 %28.42 %18.02 %
201375.13 %28.91 %20.9 %
201275.97 %27.76 %22.35 %
201176.14 %28.91 %19.96 %
201076.73 %30.39 %20.13 %
200975.9 %28.65 %14.18 %
200874.5 %27.04 %15.82 %
200774.31 %28.74 %22.78 %
200675.07 %31.33 %22.56 %
200575.66 %31.35 %17.94 %

Medtronic Aktienanalyse

What does Medtronic do?

Medtronic PLC is a globally leading medical technology company headquartered in Dublin, Ireland. The company was founded in 1949 by Earl Bakken and Palmer Hermundslie and has since developed a comprehensive portfolio of products in the field of medical devices and equipment. Medtronic's business model is focused on meeting the demand for innovative medical technology to improve the quality of life for patients and treat or alleviate diseases and disorders. The company strives to constantly invest in research and development to bring new and improved products to the market. Medtronic offers an extensive range of products that can be used in the fields of cardiology, neuromodulation, spinal surgery, diabetes, hearing aids, surgery, ophthalmology, infection prevention, percutaneous intervention procedures, and more. One of the most well-known product series is the pacemaker, which has been manufactured by Medtronic in a variety of models since 1957. In the field of neuromodulation, Medtronic is a leader in the development of implants that can treat various disorders of the nervous system. This includes deep brain stimulation (DBS) for Parkinson's disease, as well as spinal cord stimulation procedures for chronic pain and neurostimulation procedures for bladder, bowel, and gastrointestinal disorders.. In the field of spinal medicine, Medtronic offers a variety of devices that contribute to the stabilization of the spine and can be implemented through minimally invasive procedures. These include products such as plate systems, cages, spinal stabilizations, chamber drains, medication pumps, and more. In the field of diabetes, Medtronic focuses on the development of insulin pump systems that allow for more precise administration of insulin. The system also includes a sensor that continuously monitors blood sugar levels and can trigger insulin delivery as needed. Medtronic is also known for its efforts in infection prevention, offering products such as antimicrobial catheters, wound care, and hospital hygiene solutions. In addition to its products, the company is also involved in medical education and consulting. As part of these efforts, Medtronic develops training and education programs for physicians and healthcare personnel to enhance techniques and the use of devices and systems. Over the years, Medtronic has expanded its product offering through mergers and acquisitions. Currently, the company employs over 86,000 people in locations across more than 160 countries worldwide. Overall, Medtronic aims to drive innovation in medical technology and enable better healthcare for patients worldwide through its products and services. Medtronic ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Medtronic's Profit Margins

The profit margins of Medtronic represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Medtronic's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Medtronic's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Medtronic's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Medtronic’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Medtronic stock

How much profit has Medtronic made this year?

Medtronic has made 3.68 B USD this year.

How has the profit developed compared to last year?

The profit has increased by -2.18% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Medtronic publish its earnings?

Medtronic publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Medtronic?

The profits of Medtronic are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Medtronic?

You can learn more about the earnings of Medtronic by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Medtronic pay?

Over the past 12 months, Medtronic paid a dividend of 2.09 USD . This corresponds to a dividend yield of about 2.31 %. For the coming 12 months, Medtronic is expected to pay a dividend of 2.14 USD.

What is the dividend yield of Medtronic?

The current dividend yield of Medtronic is 2.31 %.

When does Medtronic pay dividends?

Medtronic pays a quarterly dividend. This is distributed in the months of January, April, July, October.

How secure is the dividend of Medtronic?

Medtronic paid dividends every year for the past 48 years.

What is the dividend of Medtronic?

For the upcoming 12 months, dividends amounting to 2.14 USD are expected. This corresponds to a dividend yield of 2.36 %.

In which sector is Medtronic located?

Medtronic is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medtronic kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medtronic from 10/11/2024 amounting to 0.7 USD, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Medtronic pay the last dividend?

The last dividend was paid out on 10/11/2024.

What was the dividend of Medtronic in the year 2023?

In the year 2023, Medtronic distributed 2.75 USD as dividends.

In which currency does Medtronic pay out the dividend?

The dividends of Medtronic are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Medtronic stock can be added to a savings plan with the following providers: Scalable Capital and Consorsbank

Andere Kennzahlen von Medtronic

Our stock analysis for Medtronic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medtronic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.